BioMarin Pharmaceutical (BMRN)

P/S ratio as of March 2025 (TTM): 4.79

According to BioMarin Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.41. At the end of 2024 the company had a P/S ratio of 4.47.

P/S ratio history for BioMarin Pharmaceutical from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	4.47	-40.5%
2023	7.51	-18.18%
2022	9.18	4.45%
2021	8.79	2.68%
2020	8.56	-4.11%
2019	8.92	-12.33%
2018	10.2	-14.62%
2017	11.9	-6.55%
2016	12.8	-32.91%
2015	19.0	5.92%
2014	18.0	-2.43%
2013	18.4	48.85%
2012	12.4	38.95%
2011	8.90	12.36%
2010	7.92	35.37%
2009	5.85	-2.4%
2008	5.99	-78.8%
2007	28.3	58.38%
2006	17.9	-42.79%
2005	31.2	41.13%
2004	22.1	-16.81%
2003	26.6	-2.43%
2002	27.2	-60.02%
2001	68.1

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Ultragenyx RARE	6.42	34.16%	🇺🇸 USA
Sangamo Therapeutics SGMO	3.61	-24.66%	🇺🇸 USA
Esperion Therapeutics ESPR	0.9645	-79.85%	🇺🇸 USA
Sanofi SNY	3.09	-35.51%	🇫🇷 France
Amicus Therapeutics FOLD	5.28	10.33%	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	5.72	19.51%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for BioMarin Pharmaceutical (BMRN)

P/S ratio as of March 2025 (TTM): 4.79